Laboratory Detection of the Antiphospholipid Syndrome via Calibrated Automated Thrombography [PDF]
, 2009 Lupus anticoagulants (LAC) consist of anti phospholipid antibodies, detected via their anti coagulant properties in vitro. Strong LAC relate to thromboembolic events, a hallmark of the anti-phospholipid syndrome.
arnout, jef +3 more
core +2 more sources
Prevalence of antiphospholipid antibodies in post-COVID and vaccinated individuals [PDF]
Infectious Diseases and Tropical MedicineOBJECTIVE: The outbreak of COVID-19 resulted mainly in respiratory disease; however, apart from that, the infection was presented with random systemic thromboembolic events.
S. Al-Rustum +4 more
doaj +1 more source
Diagnosis of antiphospholipid syndrome in routine clinical practice. [PDF]
, 2013 The updated international consensus criteria for definite antiphospholipid syndrome (APS) are useful for scientific clinical studies. However, there remains a need for diagnostic criteria for routine clinical use.
Cohen, H +3 more
core +1 more source
Journal of Immunology Research, 2022 Background. The detection of antiphospholipid antibodies (aPL) is of interest because of their importance in the pathogenesis of arterial or venous thrombosis. They could be a “second hit” of an inflammatory event such as infection.
Amal Abouda +8 more
doaj +1 more source
Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: a meta-analysis. [PDF]
, 2009 The aim of this study was to perform a meta-analysis of the association between the factor V Leiden polymorphism (FVL) and thrombosis among patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibody (aPL) positivity.
Barton, JL +6 more
core +2 more sources
Antiphospholipid Syndrome: Changing Knowledge During the Time – The ”Four P” Pattern [PDF]
, 2012 The antiphospholipid syndrome has been described for the first time by Graham Hughes in 1983 as a condition connected with thromboses or foetal losses and antiphospholipid antibodies presence.
Buliková Alena
core +2 more sources
Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities
Arthritis &Rheumatology, EarlyView.Antiphospholipid syndrome (APS) is an autoimmune thromboinflammatory disease characterized by vascular thrombosis, pregnancy morbidity, and other manifestations driven by antiphospholipid autoantibodies. In this review, we present a clinical case that illustrates some diagnostic and therapeutic challenges in managing severe, relapsing APS ...
Thalia G. Newman, Jason S. Knight
wiley +1 more source
Antiphospholipid Antibodies and COVID‐19: A Systematic Review of Clinical Implications
Immunity, Inflammation and DiseaseIntroduction As the COVID‐19 pandemic transitions, understanding the intricate dynamics of the disease becomes paramount. This systematic review explores the role of antiphospholipid antibodies in COVID‐19, focusing on their potential clinical ...
Tahereh Sabaghian +12 more
doaj +1 more source
BiomedicinesIn systemic lupus erythematosus (SLE), cardiovascular complications are among the leading causes of death. Cardiovascular risk in SLE is even higher in the presence of antiphospholipid antibodies or secondary antiphospholipid syndrome (APS).
Nikolett Nagy +7 more
doaj +1 more source
Evaluation of hearing and cochlear function by audiometric testing in patients with hyperemesis gravidarum [PDF]
, 2015 INTRODUCTION: The aim of this study was to investigate cochlear functions in patients with hyperemesis gravidarum (HG).METHODS: Twenty-nine HG patients (58 ears) and 31 healthy control subjects (62 ears) were included.
Demirtas, Ömer +5 more
core +2 more sources